No Significant Improvement in Vasospasm-Related Morbidity or All-Cause Mortality with Clazosentan after aSAH

Article Information

DOI 
http://dx.doi.org/10.1177/155989771101006
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2011 MD Conference Express

Author Information

  1. Maria Vinall
  1. Robert Loch Macdonald, MD, PhD
    1. St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
View Full Text

Article usage

AbstractFullPDF
Apr 2015500
May 2015100
Jun 2015100
Aug 2015211
Sep 2015200
Oct 2015333
Total1444

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
No Significant Improvement in Vasospasm-Related Morbidity or All-Cause Mortality with Clazosentan after aSAH
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Ischemia
Cerebrovascular Disease